1. SV40-mediated tumor selection and chromosome transfer to enrich for cystic fibrosis region
- Author
-
Julia R. Dorin, J. M. Fletcher, David J. Porteous, Maureen M. Wilkinson, Veronica van Heyningen, and Elisabeth Emslie
- Subjects
Cystic Fibrosis ,Somatic cell ,Chromosome Transfer ,Locus (genetics) ,Simian virus 40 ,Hybrid Cells ,Biology ,Transfection ,Mice ,Epidermal growth factor ,Proto-Oncogenes ,Genetics ,Animals ,Humans ,Antigens ,Cell Line, Transformed ,Repetitive Sequences, Nucleic Acid ,Chromosome 7 (human) ,Genetic transfer ,Chromosome Mapping ,Chromosome ,Cell Biology ,General Medicine ,Cell Transformation, Viral ,Molecular biology ,Human genetics ,Cell biology ,ErbB Receptors ,Cell Transformation, Neoplastic ,Genetic Techniques ,DNA Probes ,Chromosomes, Human, Pair 7 - Abstract
The somatic cell hybrid C121, with chromosome 7 as its sole human component, arose when mouse macrophages were immortalized by fusion with SV40-transformed human fibroblasts. The transforming SV40 genomes are integrated at 7q31-7q35. We show that hybrids with a reduced chromosome 7 component, but which retain markers linked to the cystic fibrosis locus, can be generated by direct in vivo tumor selection or following chromosome-mediated gene transfer and SV40-mediated cellular transformation. Our methods for chromosome fragmentation and fine-structure mapping can now be applied to the substantial number of SV40-transformed human cell lines, with independent chromosomal integration sites, already available. Our results also suggest that expression of human epidermal growth factor receptor augments the tumorigenic potential of the SV40-transformed C121 hybrid.
- Published
- 1990
- Full Text
- View/download PDF